Chugai Pharmaceutical Co Ltd banner

Wall St Price Targets

CHGCF Price Forecast
Based on 19 analysts

+27% Upside
from $42.253 today

Chugai Pharmaceutical Co Ltd (CHGCF)’s 12-month stock price forecast through October 2027 has a consensus target of $53.856, implying 27% upside. The forecast is based on price targets from 19 Wall Street analysts.

CHGCF Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for CHGCF yet.

Chugai Pharmaceutical Co Ltd Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CHGCF's stock price target?
Price Target
53.856 USD

According to Wall Street analysts, the average 1-year price target for CHGCF is 53.856 USD with a low forecast of 38.159 USD and a high forecast of 71.536 USD.

What is the Revenue forecast for Chugai Pharmaceutical Co Ltd?
Projected CAGR
10%

Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is 10%.

What is the Gross Profit forecast for Chugai Pharmaceutical Co Ltd?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 11%.

What is the Operating Income forecast for Chugai Pharmaceutical Co Ltd?
Projected CAGR
18%

Over the last 13 years, the compound annual growth rate for Operating Income has been 18%. The projected CAGR for the next -12 years is 18%.

What is the Pre-Tax Income forecast for Chugai Pharmaceutical Co Ltd?
Projected CAGR
15%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 18%. The projected CAGR for the next 3 years is 15%.

What is the Net Income forecast for Chugai Pharmaceutical Co Ltd?
Projected CAGR
15%

Over the last 13 years, the compound annual growth rate for Net Income has been 19%. The projected CAGR for the next 3 years is 15%.

Back to Top